MONIQUE SMITH: Open Payments
NPI 1922874320 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 21 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $34 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $155 |
| Amgen Inc. | 2 | $56 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Merz Pharmaceuticals, LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $15 |
Products named: QULIPTA, BOTOX, Symbravo, UPLIZNA, Xeomin, UBRELVY, AMYVID.
Industry payments across LA — which companies pay providers there.
